Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious diseases, metabolism, neonatology, neurology, oncology, pulmonology. | Ital J Pediatr | 2023 | 37679850 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| Stromal cells in the tumor microenvironment: accomplices of tumor progression? | Cell Death Dis | 2023 | 37666813 | PubTator, text mining | PubMed |
| ZEB1 promotes non-homologous end joining double-strand break repair. | Nucleic Acids Res | 2023 | 37665026 | PubTator, text mining | PubMed |
| SIRT2 inhibitor SirReal2 enhances anti-tumor effects of PI3K/mTOR inhibitor VS-5584 on acute myeloid leukemia cells. | Cancer Med | 2023 | 37658623 | PubTator, text mining | PubMed |
| Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. | J Exp Clin Cancer Res | 2023 | 37658402 | PubTator, text mining | PubMed |
| Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy. | Acta Pharm Sin B | 2023 | 37655321 | PubTator, text mining | PubMed |
| A signature of platelet reactivity in CBC scattergrams reveals genetic predictors of thrombotic disease risk. | Blood | 2023 | 37647652 | PubTator, text mining | PubMed |
| Molecular mechanism of palmitic acid and its derivatives in tumor progression. | Front Oncol | 2023 | 37637038 | PubTator, text mining | PubMed |
| Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1. | Molecules | 2023 | 37630248 | PubTator, text mining | PubMed |
| Role of Circular RNAs in Atherosclerosis through Regulation of Inflammation, Cell Proliferation, Migration, and Apoptosis: Focus on Atherosclerotic Cerebrovascular Disease. | Medicina (Kaunas) | 2023 | 37629751 | PubTator, text mining | PubMed |
| Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies. | Cells | 2023 | 37626927 | PubTator, text mining | PubMed |
| USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2. | PLoS One | 2023 | 37624791 | PubTator, text mining | PubMed |
| RNF4 and USP7 cooperate in ubiquitin-regulated steps of DNA replication. | Open Biol | 2023 | 37607592 | PubTator, text mining | PubMed |
| m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway. | J Exp Clin Cancer Res | 2023 | 37605223 | PubTator, text mining | PubMed |
| TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein. | Sci Rep | 2023 | 37604854 | PubTator, text mining | PubMed |
| Targeting the deubiquitinase USP2 for malignant tumor therapy (Review). | Oncol Rep | 2023 | 37594087 | PubTator, text mining | PubMed |
| Circulating tumor cell-derived preclinical models: current status and future perspectives. | Cell Death Dis | 2023 | 37591867 | PubTator, text mining | PubMed |
| Optimized infrared photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (IR-PAR-CLIP) protocol identifies novel IGF2BP3-interacting RNAs in colon cancer cells. | RNA | 2023 | 37582618 | PubTator, text mining | PubMed |
| AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology. | Blood Adv | 2023 | 37582288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=28